Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $1.3 million.

  • Firefly Neuroscience's Accounts Payables fell 267.73% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 267.73%. This contributed to the annual value of $1.8 million for FY2024, which is 18825.4% up from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Accounts Payables is $1.3 million, which was down 267.73% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Accounts Payables ranged from a high of $1.8 million in Q4 2024 and a low of $192213.0 during Q1 2021
  • Its 5-year average for Accounts Payables is $880300.9, with a median of $747942.0 in 2021.
  • Its Accounts Payables has fluctuated over the past 5 years, first soared by 68944.06% in 2021, then tumbled by 7544.25% in 2022.
  • Firefly Neuroscience's Accounts Payables (Quarter) stood at $650499.0 in 2021, then decreased by 11.79% to $573789.0 in 2022, then increased by 9.8% to $630000.0 in 2023, then skyrocketed by 188.25% to $1.8 million in 2024, then fell by 25.94% to $1.3 million in 2025.
  • Its Accounts Payables was $1.3 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.6 million in Q1 2025.